With compound 4d with the best anti-PD activities, we researched the inhibition of p38 phosphorylation to protect dopaminergic neurons from inflammatory responses and also antioxidant effects of promoting Nrf2 and upregulating the expression of antioxidant phase II detoxification enzymes HO-1 and GCLC. This evidence concerns the gene MAPK14 and Parkinson disease.